Featured
How a Regional Carrier Protects Against a $60B California Cat Event
While two dozen interested parties spoke at a recent California Department of Insurance workshop on the use of catastrophe modeling in pricing, offering predictable messages supporting carrier, ...
California’s Next Steps: Picking the Right Cat Models and Staffing Up
Is $11 million too much to pay for a public catastrophe model? Does the California Department of Insurance have to hire a new contingent of specialists to understand private models, if those are ...
How to Write Job Advertisements That Attract Top Insurance Talent
What's the best billboard you've ever seen? Why did it stand out? Think of job advertisements like billboards. It's something everyone can see, and the best ones are creative, memorable and lead to ...
Viewpoint: Get Ready Now for the Soft Market (Because It’s Coming)
While discussing soft market underwriting may seem ill-timed given current strong results and hard market conditions, there are worrying signs that underwriters are beginning to chase market share in ...
Viewpoint: IT Asset Disposition Is Growing Cybersecurity Threat for All Organizations
Cyber risk headlines are dominated by rising ransomware activity and soaring global data breach costs. The increased ransomware activity, driven largely by threat actor financial motives, has ...
Viewpoint: Biometric Litigation Is Significant Emerging Risk for Insurers
States are increasingly passing biometric laws to prevent companies from collecting and disseminating data such as fingerprints and facial recognition without permission. Illinois was the first to ...
Workers Compensation: Waning Benefits From Decreasing Opioid Rxs
Workers compensation has been a profit juggernaut for the property/casualty insurance industry over the past several years. Underwriting profits from the workers comp line have accounted for the ...
The Legal Tensions of Collaboration and Competition in the Life Sciences Industry
Moderna's suit against Pfizer and partner BioNtech over alleged COVID-vaccine-related patent infringement — and the targets' countersuit — might suggest an abrupt return to business as usual ...